Designed to stimulate T cell and B cell immune responses, GEN-003 is an investigational vaccine that works to potentially reduce the frequency and severity of Herpes Simplex Virus type 2 (HSV-2) infection.
The Center for the Biology of Chronic Disease (CBCD), learned recently that Genocea Biosciences has commenced a phase I/II a clinical study with its lead candidate, GEN-003. Designed to stimulate T cell and B cell immune responses, GEN-003 is an investigational vaccine that works to potentially reduce the frequency and severity of clinical outbreaks associated with moderate-to-severe Herpes Simplex Virus type 2 (HSV-2) infection.
The experimental vaccine consists of two proteins, ICP4 and gD2, as well as Matrix M, a proprietary adjuvant from Isconova AB.
Preclinical studies of GEN-003 have demonstrated the ability of the candidate vaccine to elicit strong and lasting B and T cell immune responses, and have also shown a significant impact on the severity and duration of genital herpes symptoms.
Mike Evans, from the CBCD said, “It will be very interesting to see how Genocea’s clinical trials of Gen-003 turn out. Any vaccine that drastically reduces genital herpes outbreaks or eliminates them entirely will be a welcome breakthrough.”
Until such a breakthrough is approved, however, the CBCD would like to remind the public that current treatments for genital herpes outbreaks can be inconvenient. This is due to their high cost as well as potential side effects.
Usually, therapeutic options are limited to daily antiviral medications or suppressive therapy. However, there are all natural herpes remedies on the market today that are remarkably effective in fighting the latent herpes virus.
When someone is infected with the herpes virus, after an initial period of activity where there can be up to 5 major outbreaks in a year, Herpes establishes what scientists call a latent infection. When a virus is latent, it acts as if it is asleep. It is dormant. The moment your immune system is weakened however, the Herpes virus can “wake up” and become active again.
The best defense against a latent herpes infection is a healthy immune system.
That’s why the CBCD would like to point out a Herpes remedy that boosts the immune system and helps target the latent (dormant) HSV virus.
“The key to your health is to reduce the level of the chronic viruses in your body to harmless levels.” – Dr. Hanan Polansky
The name of that herpes remedy is Gene-Eden-VIR. This scientifically designed, all-natural product helps the human body maintain low numbers of the latent (dormant) herpes virus.
By helping the body’s immune system target the latent herpes virus, people also lower their risk of developing fever blisters, cold sores, or genital herpes symptoms. This is just one reason the CBCD believes Gene-Eden-VIR is an important product.
Gene-Eden-VIR is highly efficient in fighting the latent herpes virus; each ingredient was chosen through a scientific approach. Scientists scanned thousands of scientific and medical papers published in various medical and scientific journals around the world to identify the safest, most effective natural ingredients that target the latent forms of both HSV-1 and HSV-2.
Gene-Eden-VIR is quite safe. It has been on the market for over three years, and in that time, no side effects were reported. Each capsule contains a patented formula of five all natural ingredients including selenium, camellia sinesis extract, quercetin, cinnamomum extract, and licorice extract. In addition, each bottle is GMP Certified.